We are live on ! Find out more
RhumbLine Advisers

RhumbLine Advisers Portfolio holdings

AUM $117B
1-Year Est. Return 29.66%
This Fund
S&P 500
This Quarter Est. Return
+4.83%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.91%
AUM
$46B
AUM Growth
+$2.18B
Cap. Flow
+$425M
Cap. Flow %
0.92%
Top 10 Hldgs %
15.17%
Holding
2,954
New
28
Increased
2,252
Reduced
604
Closed
50

Top Buys

Rank Stock Value
1
DD icon
DuPont de Nemours
DD
+$128M
2
BKR icon
Baker Hughes
BKR
+$26.7M
3
IQV icon
IQVIA
IQV
+$14.5M
4
OKE icon
Oneok
OKE
+$14.3M
5
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$11.2M

Sector Composition

Rank Sector Weight
1 Financials 16.64%
2 Technology 15.8%
3 Healthcare 13.57%
4 Industrials 10.87%
5 Consumer Discretionary 9.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ARQ icon
2626
Arq
ARQ
$84.6M
$255K ﹤0.01%
23,227
+205
+0.9% +$2.06K
SIEN
2627
DELISTED
Sientra, Inc.
SIEN
$255K ﹤0.01%
1,656
+34
+2% +$3.99K
IHC
2628
DELISTED
Independence Holding Company
IHC
$254K ﹤0.01%
10,049
+40
+0.4% +$885
CTLP
2629
DELISTED
Cantaloupe
CTLP
$253K ﹤0.01%
40,532
+1,130
+3% +$6.09K
NRIM icon
2630
Northrim BanCorp
NRIM
$590M
$253K ﹤0.01%
28,988
-200
-0.7% -$1.5K
TRHC
2631
DELISTED
Tabula Rasa HealthCare, Inc. Common Stock
TRHC
$253K ﹤0.01%
+9,443
New +$180K
WLDN icon
2632
Willdan Group
WLDN
$1.04B
$252K ﹤0.01%
7,753
+115
+2% +$3.68K
GHM icon
2633
Graham Corp
GHM
$1.12B
$251K ﹤0.01%
12,066
+190
+2% +$3.79K
SFST icon
2634
Southern First Bancshares
SFST
$591M
$250K ﹤0.01%
6,876
+60
+0.9% +$2.17K
VIVS
2635
VivoSim Labs
VIVS
$1.2M
$249K ﹤0.01%
467
+7
+2% +$3.72K
MR
2636
DELISTED
Montage Resources Corporation Common Stock
MR
$247K ﹤0.01%
6,592
+55
+0.8% +$2.07K
OLBK
2637
DELISTED
Old Line Bancshares, Inc.
OLBK
$246K ﹤0.01%
8,774
-165
-2% -$4.54K
PWOD
2638
DELISTED
Penns Woods Bancorp
PWOD
$245K ﹤0.01%
7,916
-313
-4% -$8.95K
LBY
2639
DELISTED
Libbey, Inc.
LBY
$245K ﹤0.01%
26,448
+320
+1% +$2.62K
CRCM
2640
DELISTED
CARE.COM, INC.
CRCM
$245K ﹤0.01%
15,431
+235
+2% +$3.48K
GNRT
2641
DELISTED
Gener8 Maritime, Inc.
GNRT
$245K ﹤0.01%
54,420
+340
+0.6% +$1.68K
LIND icon
2642
Lindblad Expeditions
LIND
$1.94B
$244K ﹤0.01%
22,818
+575
+3% +$6.02K
RNET
2643
DELISTED
RigNet, Inc.
RNET
$244K ﹤0.01%
14,168
+225
+2% +$3.84K
HONE
2644
DELISTED
HarborOne Bancorp
HONE
$243K ﹤0.01%
23,193
-278
-1% -$2.88K
MFSF
2645
DELISTED
MutualFirst Financial Inc
MFSF
$243K ﹤0.01%
6,327
+50
+0.8% +$1.76K
DHX icon
2646
DHI Group
DHX
$182M
$242K ﹤0.01%
93,179
-9,401
-9% -$21.5K
JCAP
2647
DELISTED
Jernigan Capital, Inc.
JCAP
$242K ﹤0.01%
11,752
+1,583
+16% +$32.5K
VSI
2648
DELISTED
Vitamin Shoppe Inc.
VSI
$242K ﹤0.01%
45,227
+605
+1% +$4.67K
VRS
2649
DELISTED
Verso Corporation
VRS
$241K ﹤0.01%
47,259
+11,790
+33% +$56.4K
BOJA
2650
DELISTED
Bojangles', Inc. Common Stock
BOJA
$241K ﹤0.01%
17,884
+345
+2% +$4.87K

Similar funds

RhumbLine Advisers's Q3 2017 Portfolio in Review

As of Q3 2017, RhumbLine Advisers held 2,954 positions worth $46B, up 5% from $43.8B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Trading was light in Q3 2017: portfolio turnover was 2.6%. RhumbLine Advisers opened 28 new positions and exited 50, leaving the 2,954-position portfolio largely intact.

By sector, the portfolio is most concentrated in Financials at 17% of assets, up from 16% a quarter earlier, followed by Technology and Healthcare.

  • RhumbLine Advisers's largest Q3 2017 buy was Baker Hughes: 750,985 shares worth $27.5M.
  • RhumbLine Advisers added most to DuPont de Nemours in Q3 2017, an estimated $128M increase.
  • RhumbLine Advisers's biggest Q3 2017 reduction was UnitedHealth, cutting an estimated $22.8M.
  • RhumbLine Advisers fully exited Du Pont De Nemours E I in Q3 2017, selling an estimated $114M.
  • RhumbLine Advisers's ten largest holdings make up 15% of its $46B portfolio in Q3 2017.
  • RhumbLine Advisers opened 28 new positions and closed 50 in Q3 2017.
  • RhumbLine Advisers's portfolio value rose 5% quarter-over-quarter to $46B.

Based on RhumbLine Advisers's 13F filing for Q3 2017, filed 6 Nov 2017.